Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
Moodys
Medtronic
Colorcon

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Vistapharm Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for VISTAPHARM, and what generic and branded alternatives to VISTAPHARM drugs are available?

VISTAPHARM has twenty approved drugs.



Summary for Vistapharm
US Patents:0
Tradenames:14
Ingredients:14
NDAs:20
Patent Litigation for Vistapharm: See patent lawsuits for Vistapharm

Drugs and US Patents for Vistapharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vistapharm FELBAMATE felbamate SUSPENSION;ORAL 211333-001 May 31, 2019 AB RX No No   Start Trial   Start Trial
Vistapharm PHENYTOIN phenytoin SUSPENSION;ORAL 040610-001 Aug 18, 2005 AB RX No No   Start Trial   Start Trial
Vistapharm ALBUTEROL SULFATE albuterol sulfate SYRUP;ORAL 077788-001 Jun 26, 2007 AA RX No No   Start Trial   Start Trial
Vistapharm MYCOPHENOLATE MOFETIL mycophenolate mofetil SUSPENSION;ORAL 210370-001 Feb 12, 2019 AB RX No No   Start Trial   Start Trial
Vistapharm VALPROIC ACID valproic acid SYRUP;ORAL 075782-001 Dec 22, 2000 AA RX No No   Start Trial   Start Trial
Vistapharm LACTULOSE lactulose SOLUTION;ORAL 074138-001 Sep 30, 1992 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Baxter
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.